北方稀土(600111.SH)第二大股東累計減持2002.91萬股 超出減持計劃2.91萬股
格隆匯12月5日丨北方稀土(600111.SH)公佈,2019年12月5日,公司收到第二大股東嘉鑫有限公司發來的《關於嘉鑫有限公司減持中國北方稀土(集團)高科技股份有限公司股份實施完畢的函》,其本次減持計劃已實施完畢,累計減持2002.91萬股,佔公司股份總數的0.5513%。累計減持數量超出減持計劃(計劃減持不超過2000萬股)2.9133萬股。
嘉鑫有限公司在其本次減持公司股份計劃披露前持有公司3.13億股,佔公司股份總數的8.62%;本次減持計劃實施完成後持有公司2.93億股,佔公司股份總數的8.0642%;均為無限售條件流通股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.